Invited Commentary
Balancing Quality and Timeliness in Cancer Care
Lia D. Delaney, Sherry M. Wren
JAMA Surg Published Online: August 12, 2026
doi: 10.1001/jamasurg.2026.3201
Over the past 2 decades, cancer care has become increasingly sophisticated, centralized, and multidisciplinary. These changes have improved outcomes for many patients, but as Sakowitz and colleagues1 report, timeliness is emerging as an important dimension of health care quality. As cancer care continues to regionalize, efforts to improve quality may inadvertently create barriers to timely treatment unless capacity and coordination evolve in parallel.2
This cohort study provides contemporary evidence from the National Cancer Database (capturing approximately 75% of US cancer cases) that waiting times for cancer care are increasing. From 2012 to 2023, the median time from diagnosis to first-course therapy increased across breast, colon, gastric, esophageal, lung, and pancreatic cancers. Notably, the longest delays occurred within the pathways typically relied on to deliver high-quality complex cancer care, including referral networks, academic centers, and high-volume hospitals. These findings are particularly important as oncologic care continues to consolidate. Although centralization of complex oncologic procedures (eg, esophagus, pancreas) has been associated with improved clinical outcomes and operational efficiency, benefits appear less consistent for lower-complexity procedures (eg, breast, colon).3 Concentrating lower-complexity procedures within referral centers may strain finite operative and specialty workforce capacity without improving outcomes.3
Access to cancer care is influenced by factors beyond hospital quality. Decisions regarding care reflect referral patterns, patient preferences, insurance type, second opinions, and health system marketing.4 Although the current study highlights disparities associated with social determinants of health, delays in cancer care may also arise from administrative barriers not captured in the National Cancer Database. Prior authorization requirements have significantly impacted medical and surgical treatments but remain poorly investigated in oncology care pathways.5
These findings suggest that continued regionalization of cancer care must be accompanied by parallel investments in access, coordination, and capacity. Integrated care networks, streamlined referral pathways, and improved coordination infrastructure may help preserve timely access while maintaining the benefits of specialized cancer care.6 Preserving timely access may also require a more selective approach to regionalization. Rather than concentrating all cancer care within referral centers, regionalization strategies should be matched to procedural complexity and institutional capability.3 Network-based models that maintain appropriate lower-complexity care closer to patients’ homes while reserving highly specialized operations for referral centers may better balance quality and access. Consistent with this concept, Commission on Cancer–designated integrated network programs in this study demonstrated shorter waiting times than academic centers for several cancers.1 Timeliness should be considered a core dimension of health care quality alongside traditional outcome measures.3
The modern oncology system has optimized for specialization but not necessarily for timeliness. As cancer care continues to regionalize, timely access may become as important to health care quality as specialized expertise itself.